Facebook
Google+
https://www.inovotion.com/newsletter-2/newsletter-july-2021">
Twitter
LinkedIn

INOVOTION  WILL ATTEND IMMUNO WEEK

Yan WANG, MD, PhD, INOVOTION R&D Department will give a talk at the IMMUNO WEEK conference on July 6 2021:

"The CAM assay, a powerful in vivo model for fast efficacy validation in 

immuno-oncology”.

Let’s meet at IMMUNO WEEK ! For a deep dive into Inovotion's cutting-edge technology.

We’ll give a large discount code for the conference to the first 10 applicants.

Click for further information.

Feel free to contact us directly!

INOVOTION HAS TWO NEW IN VIVO ASSAYS FOR ANGIOGENESIS! 

Our R&D team has recently remastered and validated two highly specific new assays based on the chicken Chorio-Allantoic Membrane (CAM).

The chicken embryo model is a well-recognized assay for Angiogenesis.

We are now providing Angiogenesis as a readout for our highly regarded efficacy and toxicity assays.

Let’s talk about your projects to see how these new assays will further your R&D !

CLIENT PUBLICATION

Learn how professor Michael Lisanti, MD-PhD, FRSA, FRSB, FRSC and collaborators integrated INOVOTION's technology into their study to provide evidence that elevated ATP production by mitochondrial ATP synthase is a new therapeutic target for cancer treatments, particularly for preventing tumor progression.

If you too are interested in optimizing your preclinical drug discovery with our powerful in vivo technology platform, please contact us for a free estimate!

If you wish to discover more example of Inovotion's client publications in the best peer reviewed journals please follow the link right below.

Let's discover together how Inovotion can help you realize your projects!

CLIENT TESTIMONIAL

SynDevRx, Inc. a Boston-based metabo-oncology company focusing #biotech on the link between cancer and metabolic hormone dysfunction, is working with INOVOTION for its preclinical projects!

At INOVOTION, customer satisfaction is our driving force and an inspiration to always improve ourselves.

We guarantee fast, reliable and cost-effective results so you can achieve your most challenging projects quickly and within budget.

If you are also interested in optimizing your preclinical drug discovery with our innovative in vivo technology platform, please contact us for a free estimation!

CLIENT VISIT

At Inovotion we are looking forward to meeting you in our labs! 

Come discuss your future projects with our scientific lab team!

Let’s see how Inovotion can meet your needs.

Like other clients such as Isabelle Mus-Veteau from the Institute of Molecular and Cellular Pharmacology, make an appointment and come discover Inovotion and its labs!

Our teams are ready to welcome you, feel free to contact us! 

CONTACT US

WEBINAR SERIES

Have a look at INOVOTION’s deeply useful webinar series!

Webinar #1 : HOW TO OPTIMIZE IN VIVO PRECLINICAL EFFICACITY EVALUATION OF SYNERGESTIC IMMUNO-ONCOLOGY DRUG CANDIDATE

Webinar #2 : PRECLINICAL EVALUATION OF ANTIMETASTATIC DRUG CANDIDATES USING A NEXT-GENERATION CHICKEN EMBRYO MODEL

Webinar #3 : THE CAM ASSAY, A POWERFUL IN VIVO MODEL FOR FAST EFFICACITY VALIDATION IN IMMUNO-ONCOLOGY

A main preoccupation is optimizing your preclinical and discovery studies?

Find out how to use Inovotion’s cutting-edge in vivo technology in your future projects, presented by our immuno-oncology experts.

Download them for free on our website

Also, feel free to contact us!

ALL WEBINARS 

UPCOMING EVENTS WHERE YOU CAN MEET US:

ABOUT US 

Optimizing your preclinical and Drug Discovery studies is of prime importance, and INOVOTION has developed a solution based on its unique and cutting-edge in vivo technology.

As a Contract Research Organization (CRO) dedicated to in vivo evaluation for Drug Discovery mainly in oncology and immuno-oncology, INOVOTION is a sought-after partner for Pharma and Biotech companies as well as academic labs all over the world.

Our main missions are to:

  • Help you find the best candidate anti-cancer treatment
  • Detect the first in vivo toxicity effects of your candidate compounds
  • Improve productivity and Return-On-Investment of your preclinical and Drug Discovery process by maximizing your lead optimization phase 
  • Accelerate the overall Drug Discovery process to answer unmet medical needs in oncology.

Any questions about Inovotion's technology? 

Contact us at : contact@inovotion.com

INOVOTION SAS
HQ & Lab Facilities

+33 475 549 512

5 ave du Grand Sablon
38700 La Tronche
France

INOVOTION Inc

185 Alewife Brook Parkway, Suite 210
Cambridge, MA 02138

USA

This email was sent to [[EMAIL_TO]] for marketing purposes. If it is not of interest to you, please disregard and we apologize for any inconvenience this may have caused. To prevent further emails, click here: Manage your preferences
 
Facebook
Google+
https://www.inovotion.com/newsletter-2/newsletter-july-2021">
Twitter
LinkedIn

Register for our Newsletter